Neoplasms

All Conditions

Rare Diseases

Glioma

Neoplasms, Neuroepithelial

Neuroectodermal Tumors

Neuroectodermal Tumors, Primitive

Neoplasms, Germ Cell and Embryonal

Neoplasms by Histologic Type

Neoplasms, Glandular and Epithelial

Neoplasms, Nerve Tissue

Neuroepithelioma

The intervention occurs only one time (for 2h30), the MRI examination is divided as follow:

* Cinicial MRI (50 minutes)
* Research MRI (Phosphorus Spectroscopy, Sodium Imaging)

Diagnostic test

Rémy GUILLEVIN, Pr

Glioma is a tumor of the central nervous system. These lesions are sorted with the WHO ranking regarding the tumoral oncotype. The tumoral MRI assessment is the first step before any medical decision. Currently, only anatomical biopsy can give the tumor grade definition and help to define the most adapted treatment.

Virtual Biopsy Development to Identify Patient's Glioma Grade at the CHU of Poitiers Using Magnetic Resonance Imaging

Evaluate the diagnostic capabilities of artificial intelligence algorithms for virtual biopsy based on sensitivity and specificity

Poitiers University Hospital

Skin and Connective Tissue Diseases

Breast Neoplasms

Breast Diseases

Skin Diseases

Antineoplastic Agents

All Drugs and Chemicals

Trastuzumab

Hormones

Estrogens

Antineoplastic Agents, Immunological

Hormone Antagonists

Endocrine treatment versus no endocrine therapy (in women with hormone receptor positive1 disease).

Endocrine therapy

Radiotherapy

Trastuzumab versus no trastuzumab (in women with HER2-positive disease).

Herceptin

Chemotherapy

Type of surgery (partial mastectomy, mastectomy, other).

Type of breast cancer surgery

Age at diagnosis (\<35, 35-\<50, 50-\<70, ≥70).

Age at diagnosis

Screen detected tumor

Menopausal status (premenopausal, postmenopausal).

Menopausal status at diagnosis

Tumor size

Estrogen receptor (ER) status

Tumor grade

HER2-status

Intrinsic subgroup proxy (Luminal A, Luminal B (HER2-negative), Luminal B (HER2-positive), HER2-positive (non-luminal), Triple negative).

Intrinsic subgroups of breast cancer

Nodal status

Because of mammography screening increasingly more women are diagnosed with centimeter or subcentimeter node-negative breast cancer (i.e., T1abN0); these tumors account for approximately 19% of all newly diagnosed breast cancers in Sweden. Although the long term relapse-free survival rates among patients with such tumors is as high as ≥90%, some reports suggest that certain patient subgroups may have rates \<75%. Firmly established prognostic and predictive factors for patients with T1abN0 tumors are, however, lacking. This is a nationwide, register-based cohort study investigating prognostic and predictive factors in women with centimeter or subcentimeter breast cancer. The study hypotheses are: 1) Established prognostic and/or predictive factors in overall breast cancer are prognostic and/or predictive factors also in centimeter or subcentimeter node-negative breast cancer; 2) The established relative reduction in risk of recurrence and death of adjuvant treatment for overall breast cancer are similar in centimeter or subcentimeter node-negative breast cancer.

Prognostic and Predictive Factors for Small Breast Tumors

Prognosis, Prognostic Factors and Predictive Factors in Centimeter or Subcentimeter Node-negative Breast Cancer

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Virtual Biopsy Development to Identify Patient's Glioma Grade at the CHU of Poitiers Using Magnetic Resonance Imaging	NCT04313140	Development of ... Tumor Grade Artificial Inte... Clinical Radiological	Diagnostic test	18 Years -	Poitiers University Hospital
Prognostic and Predictive Factors for Small Breast Tumors	NCT03390608	Breast Cancer	Endocrine thera... Radiotherapy Herceptin Chemotherapy Type of breast ... Age at diagnosi... Screen detected... Menopausal stat... Tumor size Estrogen recept... Tumor grade HER2-status Intrinsic subgr... Nodal status	- 100 Years	Karolinska Institutet
Virtual Biopsy Development to Identify Patient's Glioma Grade at the CHU of Poitiers Using Magnetic Resonance Imaging	NCT04313140	Development of ... Tumor Grade Artificial Inte... Clinical Radiological	Diagnostic test	18 Years -	Poitiers University Hospital
Virtual Biopsy Development to Identify Patient's Glioma Grade at the CHU of Poitiers Using Magnetic Resonance Imaging	NCT04313140	Development of ... Tumor Grade Artificial Inte... Clinical Radiological	Diagnostic test	18 Years -	Poitiers University Hospital

Spots Global Cancer Trial Database for tumor grade

Every month we try and update this database with for tumor grade cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

Spots Global Cancer Trial Database for tumor grade

Every month we try and update this database with for tumor grade cancer trials from around the world to help patients and their families find trials that might be right for them. We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

Every month we try and update this database with for tumor grade cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.